Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3017312	ts-igh-d	— (—)	195	217	100.00%	Distribution not available
3017312	b-igh-d	— (—)	16	16	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Primary_lymphoid and hematopoietic malignant neoplasms

156

113.01

305.22

1.1

—

Liquid cancers, helper endpoint

160

117.22

276.94

1.1

1.0

—

Non-follicular lymphoma

93.19

173.99

1.1

1.0

—

Enlarged lymph nodes

78.41

173.94

1.2

1.0

—

Malignant neoplasm

19.09

76.87

1.1

1.0

—

Malignant neoplasm, wide definition for exclusion

17.61

74.22

1.1

1.0

—

Solid cancers, helper endpoint

17.51

68.46

1.1

1.0

—

Any event in cancer register

13.50

66.74

1.1

—

Fever of other and unknown origin

12.48

60.26

1.2

1.1

—

Diffuse large B-cell lymphoma, helper endpoint

+∞

43.94

1.1

0.0

—

Diffuse large B-cell lymphoma, including Hilmo

+∞

43.94

1.1

0.0

—

Diffuse large B-cell lymphoma

+∞

43.94

1.1

0.0

—

Non-Hodgkin lymphoma, all

+∞

42.89

1.3

0.0

—

Neoplasms

17.23

40.85

1.2

1.1

—

General symptoms and signs

7.38

39.78

1.1

—

Other medical care

7.11

38.56

1.1

—

Malignant neoplasm of skin

20.06

38.05

1.2

1.0

—

Marginal zone B-cell lymphoma, including Hilmo

+∞

37.93

1.1

0.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

22.22

37.02

1.2

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

21.22

34.70

1.2

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

120

4.72

31.56

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.84

30.05

1.1

—

Marginal zone B-cell lymphoma

+∞

27.49

1.1

0.0

—

ILD medications

4.58

27.29

1.1

—

First line medication for Crohn's disease

4.56

25.14

1.2

1.1

—

Bacterial infection, other or unspecified

4.93

23.25

1.1

—

Bacterial infection, other or unspecified

4.98

22.84

1.1

—

Other diseases of blood and blood-forming organs, wide

8.08

21.73

1.2

1.1

—

Follicular lymphoma, hilmo

37.75

20.80

1.1

1.0

—

Other bacterial diseases

121

3.84

20.61

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

6.31

20.50

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

136

4.03

20.18

1.1

—

Other bacterial diseases

119

3.73

19.78

1.1

—

Any gastric operation

6.23

17.88

1.0

1.1

—

GASTRO-related operations

6.23

17.88

1.0

1.1

—

Inflammatory bowel disease treatment related agents

121

3.28

16.07

1.1

—

Oxycodone

4.65

16.04

1.1

1.2

—

Oral corticosteroids

120

3.31

15.71

1.1

—

Persons encountering health services for specific procedures and health care

123

3.22

14.89

1.1

—

Chronic lymphocytic leukaemia, helper endpoint

+∞

14.61

1.1

0.0

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

+∞

14.61

1.1

0.0

—

Chronic lymphocytic leukaemia

+∞

14.61

1.1

0.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

124

3.54

14.43

1.1

—

Abnormal findings on diagnostic imaging of lung

101

3.89

14.11

1.1

—

Basal cell carcinoma

16.62

14.01

1.1

1.0

—

Basal cell carcinoma, including avohilmo

15.04

13.53

1.1

1.0

—

Lymphoid leukaemia

24.45

12.46

1.1

1.0

—

112

3.08

12.14

1.2

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

112

3.08

12.14

1.2

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

140

2.88

11.79

1.2

1.1

—

Influenza and pneumonia

139

2.84

11.70

1.2

1.1

—

Malignant neoplasm of digestive organs

16.68

11.64

1.1

1.0

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

+∞

11.52

1.3

0.0

—

Anaemias

14.52

11.06

1.1

1.0

—

All pneumoniae

141

2.80

11.04

1.2

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

8.54

10.99

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

142

2.79

10.85

1.2

1.1

—

Purpura and other haemorrhagic conditions

9.58

10.72

1.1

1.0

—

Pneumonia, organism unspecified

130

2.86

10.47

1.2

1.1

—

ILD medications: immunosuppressive drugs

3.61

10.20

1.1

—

Any death

104

3.03

9.69

1.3

1.1

—

Hepatomegaly and splenomegaly, not elsewhere classified

+∞

9.41

1.0

0.0

—

Thrombocytopenia, unspecified

13.70

9.17

1.1

1.0

—

Personal history of malignant neoplasm

12.56

8.86

1.1

1.0

—

Aplastic and other anaemias

3.32

8.77

1.1

1.2

—

Malignant immunoproliferative diseases

+∞

8.36

1.5

0.0

—

Malignant neoplasm of eye, brain and central nervous system

+∞

8.34

1.3

0.0

—

Malignant neoplasm of stomach

+∞

8.34

1.0

0.0

—

Malignant neoplasm of stomach, including Hilmo

+∞

8.33

1.0

0.0

—

Malignant neoplasm, without specification of site, including Hilmo

+∞

8.33

1.1

0.0

—

Other anaemias

3.36

8.18

1.1

—

Septicaemia

3.48

7.69

1.3

1.1

—

Other and unspecified anaemias

3.26

7.53

1.1

—

Malignant neoplasm, without specification of site

+∞

7.30

1.0

0.0

—

Other septicaemia

3.63

7.30

1.3

1.1

—

Transplanted organ and tissue status

7.92

7.09

1.3

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

10.75

6.97

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

159

2.42

6.91

1.2

1.1

—

Certain disorders involving the immune mechanism

5.44

6.89

1.1

—

Certain infectious and parasitic diseases

2.56

6.85

1.0

1.1

—

Malaise and fatigue

3.93

6.72

1.0

1.1

—

Other noninfective gastroenteritis and colitis

4.00

6.60

1.2

1.1

—

Other disorders of white blood cells

18.07

6.26

1.0

—

Other autoimmune haemolytic anaemias

+∞

6.26

1.0

0.0

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

+∞

6.26

1.0

0.0

—

Malignant neoplasm of other connective and soft tissue

+∞

6.25

1.2

0.0

—

Malignant neoplasm of mesothelium and soft tissue

+∞

6.25

1.2

0.0

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

+∞

6.25

1.2

0.0

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

+∞

6.25

1.8

0.0

—

Dialysis, with operation codes

6.26

6.15

1.5

1.1

—

Other diseases of intestine

6.01

5.98

1.1

1.0

—

Immunodeficiencies

15.06

5.90

1.1

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

14.83

5.85

1.1

1.0

—

Benign neoplasms

114

2.27

5.71

1.1

—

Zoster [herpes zoster]

5.36

5.52

1.2

1.0

—

COPD differential diagnosis

2.58

5.50

1.1

—

ILD differential diagnosis

2.58

5.50

1.1

—

Noninfective enteritis and colitis

2.76

5.43

1.2

1.1

—

Agranulocytosis

7.07

5.43

1.0

—

Excluding asthma or asthma-COPD overlap

2.54

5.36

1.1

—

Viral infections characterized by skin and mucous membrane lesions

2.78

5.28

1.1

—

Explicit Sepsis

2.73

5.24

1.3

1.1

—

Mantle cell lymphoma, including Hilmo

+∞

5.21

1.2

0.0

—

Malignant neoplasm of small intestine, including Hilmo

+∞

5.21

1.2

0.0

—

Rare circulating lymphoid malignancy, including Hilmo

+∞

5.21

1.2

0.0

—

Autoimmune diseases excluding thyroid diseases

131

2.08

4.99

1.2

1.1

—

Other pulmonary diagnosis

2.47

4.96

1.1

—

Syncope and collapse

3.61

4.93

1.1

—

Nephropathy related operations

5.43

4.90

1.4

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

129

2.08

4.88

1.1

—

Malignant melanoma, including Hilmo

14.01

4.57

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs

11.10

4.54

1.3

1.0

—

Other skin changes

4.82

4.49

1.3

1.0

—

Symptoms and signs involving the digestive system and abdomen

111

2.08

4.48

1.2

1.1

—

L04AD Calcineurin inhibitors

5.80

4.43

1.1

—

Certain infectious and parasitic diseases

2.47

4.41

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

4.81

4.18

1.1

—

Chronic gastritis

2.91

4.16

1.1

—

Other viral diseases, not elsewhere classified

3.40

4.14

1.2

1.1

—

Noninfectious colitis NAS

5.25

4.13

1.3

1.0

—

Zoster [herpes zoster]

108

2.37

4.06

1.3

1.1

—

Pain, not elsewhere classified

5.00

3.99

1.1

1.0

—

Other viral diseases

2.84

3.99

1.2

1.1

—

Codes for special purposes

105

2.38

3.95

1.0

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

140

1.90

3.91

1.1

—

Abdominal and pelvic pain

111

1.99

3.90

1.2

1.1

—

Malignant neoplasm of bronchus and lung, including Hilmo

9.77

3.82

1.1

1.0

—

Diaphragmatic hernia

2.60

3.79

1.0

1.1

—

COPD/asthma/ILD related infections

112

1.97

3.78

1.1

—

COPD/asthma related infections

112

1.97

3.78

1.1

—

malignant neoplasm of female genital organs

11.94

3.75

1.0

—

Bacterial pneumoniae

2.59

3.69

1.1

—

Budesonide

5.01

3.68

1.1

1.0

—

Other viral diseases

2.99

3.66

1.1

1.2

—

Covid-19 confirmed case

2.60

3.63

1.1

—

Persons encountering health services in other circumstances, wide

140

1.84

3.59

1.1

—

Migraine without aura

4.00

3.59

1.1

—

Provisional assignment of new diseases of uncertain etiology

105

2.28

3.49

1.0

1.1

—

Other viral diseases, not elsewhere classified

3.86

3.47

1.2

1.1

—

Asthma, excluding more controls

2.22

3.43

1.0

1.1

—

Melanocytic naevi

2.76

3.41

1.1

—

Malignant neoplasm of bronchus and lung

9.97

3.36

1.2

1.0

—

Collagenous colitis

5.72

3.34

1.1

1.0

—

Examination and observation for other reasons

2.23

3.33

1.0

1.2

—

Asthma

2.17

3.27

1.0

1.1

—

Autoimmune diseases related-to ILD

162

1.90

3.22

1.3

1.1

—

Inflammatory bowel disease

2.67

3.22

1.3

1.1

—

All kidney diseases

157

1.83

3.20

1.1

—

Gastroduodenal ulcer

2.66

3.20

1.0

1.1

—

Rash and other nonspecific skin eruption

5.34

3.19

1.0

—

Bacterial pneumonia, not elsewhere classified

2.52

3.16

1.1

1.0

—

Gastrointestinal diseases

2.51

3.15

1.1

1.0

—

Parasetamol

2.11

3.15

1.0

1.1

—

Oedema, not elsewhere classified

3.74

3.13

1.2

1.1

—

Other and unspecified dermatitis

111

2.16

3.11

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

146

1.83

3.10

1.2

1.1

—

Medical observation and evaluation for suspected diseases and conditions

2.12

3.08

1.0

1.2

—

Other disorders of the genitourinary system

4.01

3.08

1.1

1.0

—

Dental caries

2.81

3.06

1.1

1.0

—

L01XX Other antineoplastic agents

7.52

3.05

1.2

1.0

—

Gastric ulcer

3.34

3.01

1.0

1.1

—

Used for control exclusion in common control thyroid runs

120

1.81

2.99

1.1

—

Malignant melanoma of skin, including Hilmo

10.01

2.98

1.0

—

Asthma, unspecified (mode)

2.35

2.97

1.0

1.1

—

Conjunctivitis (acute, non atopic)

2.74

2.96

1.4

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.54

2.95

1.1

—

Intestinal infectious diseases

155

1.73

2.92

1.2

1.1

—

Bacterial pneumonia (organism specified)

2.19

2.91

1.1

—

Acute pharyngitis

4.67

2.89

1.4

1.0

—

ILD, hospital admissions 1, main diag only

3.71

2.87

1.1

1.0

—

DVT of lower extremities and pulmonary embolism

2.20

2.86

1.1

—

Implicit Sepsis

132

1.89

2.85

1.0

1.1

—

Implicit viral Sepsis

3.16

2.84

1.1

—

Viral Sepsis

3.16

2.84

1.1

—

Asthma and allergy, excluding more controls

6.58

2.84

1.0

—

Asthma and allergy

6.58

2.84

1.0

—

Bronchitis

160

1.73

2.81

1.1

—

Implicit Sepsis

134

1.85

2.78

1.0

1.1

—

ILD, hospital admissions

3.58

2.78

1.1

1.0

—

Other interstitial pulmonary diseases

3.58

2.78

1.1

1.0

—

Interstitial lung disease

3.58

2.78

1.1

1.0

—

Interstitial lung disease endpoints

3.58

2.78

1.1

1.0

—

Malignant neoplasm of breast, HER-positive

5.46

2.77

1.1

1.0

—

Sarcoidosis

3.92

2.77

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

154

1.75

2.77

1.2

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.72

2.76

1.0

1.1

—

Asthma (mode)

2.07

2.76

1.0

1.1

—

Other ulcerative colitis

8.35

2.75

1.4

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

5.40

2.75

1.1

1.0

—

Renal tubulo-interstitial diseases

149

1.80

2.70

1.1

—

ILD, hospital admission 2, with pulmonary infections

6.01

2.69

1.2

1.0

—

Asthma, unspecified (mode), excluding more controls

2.29

2.69

1.0

1.1

—

Bell's palsy

4.22

2.67

1.1

—

Other symptoms and signs involving the digestive system and abdomen

4.21

2.67

1.3

1.1

—

Any reimbursement code in KELA

2.38

2.62

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

123

1.87

2.62

1.1

—

Nausea and vomiting

2.94

2.62

1.1

—

Other disorders of lacrimal gland

2.30

2.57

1.2

1.1

—

Dermatitis

141

1.91

2.56

1.1

—

Carcinoma in situ of skin of other and unspecified parts of face

5.46

2.54

1.0

—

All influenza

2.73

2.54

1.2

1.0

—

Benign neoplasm: salivary glands, exclude unknown (D119)

4.38

2.47

1.1

1.0

—

Viral pneumonia

4.38

2.47

1.0

1.1

—

Ulcerative colitis

2.67

2.44

1.3

1.1

—

Convulsions, not elsewhere classified

4.32

2.44

1.0

—

Other extrapyramidal and movement disorders in other diseases

2.55

2.44

1.2

1.1

—

Infections, IBD-co-morbidities

3.57

2.43

1.1

—

Intestinal infectious diseases

169

1.71

2.43

1.2

1.1

—

Acute alcohol intoxication

0.00

2.42

0.0

1.2

—

Other inflammatory liver diseases

5.01

2.40

1.0

—

Headache

2.40

2.38

1.1

1.0

—

Ovarian dysfunction

6.26

2.37

1.0

—

141

1.65

2.36

1.2

1.1

—

Migraine without aura and triptan purchases

3.64

2.36

1.0

—

Implicit bacterial Sepsis

2.04

2.34

1.0

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

4.62

2.27

1.2

1.0

—

Inflammatory diseases of the central nervous system

4.62

2.27

1.0

—

Malignant neoplasm of breast, HER2-negative

3.74

2.27

1.1

1.0

—

Malignant neoplasm of breast

3.73

2.26

1.1

1.0

—

Tramadol

107

1.78

2.22

1.1

—

Implicit fungal Sepsis

5.56

2.21

1.0

—

Other Crohn's disease

5.56

2.21

1.2

1.1

—

Streptococcal septicaemia

5.56

2.21

1.2

1.0

—

All influenza (not pneumonia)

3.34

2.17

1.4

1.1

—

Gonarthrosis, primary, with knee surgery

134

0.36

2.17

1.2

1.1

—

Allergic asthma (mode)

3.04

2.16

1.0

—

Viral warts

4.29

2.15

1.2

1.1

—

Benign neoplasm of major salivary glands

3.69

2.15

1.1

1.0

—

Crohn disease

3.69

2.15

1.1

—

Pulmonary heart disease

2.30

2.14

1.1

1.0

—

Pulmonary embolism

2.30

2.14

1.1

1.0

—

Implicit viral Sepsis

2.30

2.14

1.1

—

Autoimmune diseases

131

1.63

2.13

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

3.45

2.11

1.1

1.0

—

Malignant neoplasm of breast, including Hilmo

3.45

2.11

1.1

1.0

—

L04AX Other immunosuppressants

130

1.85

2.11

1.1

—

Other diseases of intestines

135

1.64

2.10

1.3

1.1

—

Hypertensive diseases (excluding secondary)

1.94

2.09

1.1

—

Allergic asthma (mode), excluding more controls

2.94

2.09

1.0

—

Erysipelas

1.94

2.08

1.1

—

Multiple myeloma and malignant plasma cell neoplasms

5.01

2.07

1.2

1.0

—

Drug-induced neutropenia

5.01

2.07

1.0

—

Other respiratory diseases principally affecting the interstitium

2.70

2.06

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

144

1.75

2.06

1.3

1.1

—

Diseases of oesophagus, stomach and duodenum

148

1.62

2.05

1.0

1.1

—

Fibromyalgia

4.00

2.04

1.0

—

Diabetes mellitus

170

0.48

2.01

1.1

—

Open wound of lower leg

3.08

2.01

1.3

1.1

—

Diabetes, varying definitions

170

0.48

2.00

1.1

—

Asthma (only as main-diagnosis)

1.90

2.00

1.0

1.1

—

Pleural effusion

2.81

2.00

1.0

—

Venous thromboembolism

128

1.81

1.99

1.1

—

Other disorders of eye and adnexa

3.34

1.96

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

157

1.64

1.96

1.1

—

1.99

1.94

1.1

—

Nonspecific lymphadenitis

4.55

1.94

1.2

1.0

—

Second line medication for Crohn's disease

134

1.79

1.94

1.1

—

Gastro-oesophageal reflux disease

134

1.74

1.94

1.1

—

Gingivitis and periodontal diseases

133

1.59

1.93

1.1

—

Erysipelas

107

1.78

1.91

1.1

—

Abnormal findings on diagnostic imaging of other body structures

3.18

1.88

1.0

1.1

—

Asthma, hospital admission 2, infections

126

1.79

1.85

1.0

1.1

—

Asthma-related infections

126

1.79

1.85

1.0

1.1

—

Myalgia

2.39

1.85

1.1

1.0

—

Asthma-related pneumonia

2.02

1.84

1.0

1.1

—

Asthma, hospital admissions 3, pneumonia

2.02

1.84

1.0

1.1

—

Asthma-related pneumonia or sepsis

2.02

1.84

1.0

1.1

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

3.53

1.83

1.0

1.2

—

Disorders of lacrimal system

1.93

1.83

1.2

1.1

—

Benign neoplasm: Adrenal gland

4.17

1.82

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

4.17

1.82

1.2

1.0

—

Heartburn

4.17

1.82

1.2

1.1

—

Caries of dentine

2.38

1.82

1.0

—

Acute sinusitis

1.89

1.80

1.1

—

Monoamine oxidase A inhibitors

3.05

1.80

1.0

1.1

—

Benign neoplasm of other and unspecified endocrine glands

3.05

1.80

1.0

—

Other inflammation of eyelid

3.05

1.80

1.0

—

Coxarthrosis, primary

144

0.41

1.79

1.1

—

Bacterial intestinal infections, IBD co-morbidities

2.76

1.79

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

1.85

1.78

1.0

1.1

—

Sleep disorders (combined)

147

1.54

1.78

1.0

1.1

—

Other diseases of pleura

1.85

1.76

1.1

1.2

—

Migraine

1.92

1.75

1.1

—

Ptosis of eyelid

3.34

1.74

1.0

—

Viral warts

2.50

1.73

1.1

—

Asthma (diagnoses ohter than nonallergic)

172

1.59

1.73

1.0

1.1

—

Stroke, excluding SAH

132

0.44

1.73

1.1

—

Cough

1.89

1.72

1.1

—

Other bacterial intestinal infections

2.67

1.72

1.1

—

Restless leg syndrome

2.92

1.72

1.1

—

Viral infections of the central nervous system

3.85

1.71

1.0

1.1

—

Persons encountering health services for specific procedures, not carried out

3.85

1.71

1.2

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

3.85

1.71

1.0

—

Other diseases of biliary tract

3.85

1.71

1.2

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

2.06

1.69

1.1

1.0

—

Acute appendicitis

145

1.68

1.69

1.1

—

Use of memantine

0.00

1.69

0.0

1.0

—

Use of other anti-dementia drugs

0.00

1.69

0.0

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.76

1.63

1.1

—

Acute tubulo-interstitial nephritis

122

1.70

1.62

1.2

1.1

—

Acute upper respiratory infections

158

1.52

1.62

1.3

1.1

—

Viral infections of the central nervous system

3.58

1.61

1.0

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

3.57

1.61

1.0

—

Explicit bacterial Sepsis

3.57

1.61

1.2

1.1

—

Other bacterial intestinal infections

2.38

1.61

1.1

—

Tonsillectomy and adenotomy

1.84

1.59

1.2

1.1

—

Opioids

112

1.58

1.59

1.1

—

Other reaction to severe stress, and adjustment disorders

2.06

1.59

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

138

1.59

1.58

1.0

1.1

—

Benign neoplasm: Skin of other and unspecified parts of face

3.00

1.58

1.0

—

3.00

1.58

1.0

1.2

—

Depression medications

3.35

1.57

1.0

—

Polyuria

2.20

1.56

1.0

1.1

—

Diagnoses used for exclusion with ILD

2.11

1.54

1.1

—

Irregular menses

2.01

1.54

1.0

—

Stroke, including SAH

136

0.48

1.53

1.1

—

Chronic apical periodontitis

157

1.49

1.53

1.1

—

Other disorders of skin and subcutaneous tissue

149

1.61

1.53

1.1

—

Bacterial Sepsis

1.78

1.52

1.1

—

Type 2 diabetes

168

0.56

1.52

1.1

—

Nontoxic single thyroid nodule

3.34

1.52

1.0

—

Benign neoplasm: Parotid gland

3.34

1.52

1.2

1.0

—

Ulcerative colitis, NAS

2.86

1.50

1.3

1.0

—

ILD medications: azathioprine

2.86

1.50

1.2

1.1

—

Azathioprine

2.86

1.50

1.2

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

2.16

1.50

1.2

1.1

—

Acute alcohol intoxication, ICD10

0.00

1.49

0.0

1.2

—

Ischaemic Stroke, excluding all haemorrhages

127

0.47

1.49

1.1

—

Asthma, including avohilmo

165

1.46

1.49

1.0

1.1

—

Use of hypnotics and sedatives

146

1.49

1.46

1.2

1.1

—

1.85

1.46

1.0

1.1

—

Implicit bacterial Sepsis

1.82

1.45

1.1

—

Appendicitis, broad definition

154

1.59

1.45

1.1

—

Other disorders of bone

2.37

1.45

1.3

1.1

—

Spondyloarthritis

2.50

1.45

1.3

1.0

—

Care involving use of rehabilitation procedures

107

1.72

1.45

1.1

—

Sicca syndrome [Sjögren]

3.13

1.44

1.0

—

Aortic valve malfunction, age under 60 years

3.13

1.44

1.0

1.2

—

Benign neoplasm of eye and adnexa

3.13

1.44

1.2

1.0

—

Overexertion and strenuous or repetitive movements

3.13

1.44

1.6

1.1

—

Other complications of surgical and medical care, not elsewhere classified

3.13

1.44

1.0

—

Diseases of appendix

154

1.58

1.43

1.1

—

Other embolism and thrombosis

2.73

1.43

1.2

1.1

—

Mucosal proctocolitis

2.73

1.43

1.3

1.0

—

Intestinal stricture

1.97

1.43

1.1

—

DVT of lower extremities

2.31

1.42

1.1

—

Acute appendicitis, no complications

117

1.70

1.42

1.1

—

Glucosamine medication

111

0.43

1.42

1.0

1.1

—

Other acute lower respiratory infections

112

1.70

1.41

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

1.82

1.40

1.1

—

Osteopathies and chondropathies

124

1.65

1.40

1.1

—

Type 2 diabetes, definitions combined

164

0.57

1.40

1.1

—

Early onset COPD, excluding more controls

2.41

1.39

1.6

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

115

1.69

1.38

1.3

1.1

—

Lyme disease

1.94

1.38

1.0

1.1

—

Spirochaetal infections, other/unspecified

1.94

1.38

1.0

1.1

—

Other spirochaetal diseases

1.94

1.38

1.0

1.1

—

Other spirochaetal diseases

1.94

1.38

1.0

1.1

—

Pain in joint

1.67

1.37

1.0

1.1

—

Chronic sinusitis

1.80

1.36

1.0

1.1

—

Lower back pain or/and sciatica

170

1.46

1.36

1.1

—

Diseases of the skin and subcutaneous tissue

121

1.49

1.36

1.0

1.1

—

Disorders of continuity of bone

2.94

1.36

1.0

1.1

—

Other pleural conditions

2.94

1.36

1.0

—

Fentanyl

2.94

1.35

1.0

—

Polycystic ovarian syndrome, consortium definition

1.67

1.35

1.0

—

Pain in throat and chest

122

1.53

1.34

1.0

1.1

—

Appendectomy

144

1.59

1.34

1.1

—

Conjunctivitis

145

1.55

1.34

1.2

1.1

—

Urolithiasis

1.87

1.34

1.0

1.1

—

Factors influencing health status and contact with health services

2.28

1.33

1.2

1.0

—

Hypothyroidism and >3 levothyroxin purchases

3.14

1.33

1.2

1.0

—

Hypothyroidism, levothyroxine purchases

3.14

1.33

1.2

1.0

—

Hypothyroidism (congenital or acquired)

3.14

1.33

1.2

1.0

—

Obesity, other/unspecified

1.97

1.32

1.2

1.1

—

Heart failure, not strict

134

1.52

1.31

1.1

—

Recurrent aphthous stomatitis , including avohilmo

2.50

1.30

1.0

—

Disorders of conjunctiva

160

1.50

1.29

1.2

1.1

—

5-aminosalicylic acid

2.35

1.29

1.3

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

2.77

1.28

1.0

—

Coxarthrosis, primary, with hip surgery

125

0.45

1.28

1.0

1.1

—

Presence of other functional implants

112

0.50

1.28

1.0

1.1

—

Coronary atherosclerosis

123

0.51

1.28

1.0

1.1

—

Acute bronchitis

1.79

1.27

1.1

—

Other heart diseases

1.73

1.27

1.1

—

Radiculopathy

2.29

1.26

1.0

1.1

—

Stomatitis and related lesions

2.29

1.26

1.0

1.1

—

L04AA Selective immunosuppressants

2.05

1.26

1.1

—

Disorders of other endocrine glands

1.75

1.26

1.1

—

Chronic periodontitis, including avohilmo

162

1.45

1.23

1.1

—

Periodontitis

162

1.44

1.22

1.1

—

Speech therapy

2.04

1.21

1.0

1.1

—

Hydronephrosis

2.63

1.21

1.0

—

Paralytic ileus and intestinal obstruction

1.96

1.21

1.0

1.1

—

Inflammatory disease of uterus

2.63

1.21

1.0

1.1

—

Cerebral palsy and other paralytic syndromes

2.63

1.21

1.2

1.1

—

Lung diseases due to external agents

2.63

1.21

1.0

—

Other obstetric conditions, not elsewhere classified

2.21

1.21

1.0

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.21

1.21

1.0

1.1

—

Diseases of liver

1.80

1.20

1.0

1.2

—

Chronic periodontitis, complicated

131

1.59

1.19

1.2

1.1

—

Diabetes medication

172

0.62

1.18

1.1

—

Type 2 diabetes, strict (exclude DM1)

163

0.61

1.18

1.1

—

Other or unspecified ileus, impaction or obstruction

2.11

1.18

1.0

1.1

—

Other benign neoplasms of skin

1.77

1.16

1.1

—

Actinic keratosis

1.74

1.15

1.1

—

Hypertension, essential

110

1.49

1.15

1.1

—

Other and unspecified polyneuropathies, also in other diseases

2.05

1.15

1.1

—

Alcohol abuse, main dg

0.00

1.15

0.0

1.1

—

Alcohol abuse, main dg, excluding more controls

0.00

1.15

0.0

1.2

—

Use of donepezil

0.00

1.15

0.0

1.0

—

Abrasion of teeth

1.81

1.14

1.0

1.1

—

Extrapyramidal and movement disorders

1.72

1.14

1.2

1.1

—

Other diseases of urinary system

133

1.44

1.13

1.1

—

Codeine or tramadol medication

157

1.39

1.13

1.0

1.1

—

Cystitis

112

1.49

1.11

1.1

—

Disorders of adult personality and behaviour

1.96

1.11

1.0

1.1

—

Other heart diseases, wide

136

1.44

1.10

1.1

—

Finngen Rheumatological endpoints

136

1.42

1.08

1.2

1.1

—

Iridocyclitis

1.95

1.08

1.3

1.1

—

IBD patients in KELA-register

1.95

1.08

1.3

1.1

—

In situ neoplasms

1.73

1.08

1.1

—

Sciatica+with lumbago

110

1.59

1.08

1.0

1.1

—

Other disorders of patella

2.19

1.08

1.1

1.0

—

Dermatitis and eczema

170

1.39

1.07

1.1

—

Codeine

112

1.46

1.07

1.0

1.1

—

Other intervertebral disc disorders

120

1.45

1.05

1.1

—

Primary gonarthrosis, bilateral

127

0.54

1.04

1.1

—

Other maternal disorders predominantly related to pregnancy

0.44

1.03

1.0

1.1

—

Osteoporosis

1.96

1.03

1.1

1.0

—

Abnormalities of breathing

126

1.43

1.03

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

168

0.65

1.03

1.1

—

Other diseases of liver

2.06

1.02

1.0

1.1

—

Cardiovascular diseases

1.58

1.02

1.1

—

Hernia

152

1.41

1.02

1.1

—

Deviated nasal septum

1.73

1.02

1.5

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

130

1.43

1.01

1.1

—

Organic, including symptomatic, mental disorders

0.51

1.00

1.0

1.1

—

Lumbar disc prolapse

118

1.49

1.00

1.0

1.1

—

Hypertensive diseases

114

1.44

0.99

1.1

—

Hypertension

114

1.44

0.99

1.1

—

Biguanides

168

0.65

0.98

1.1

—

Candidiasis

1.84

0.98

1.0

1.1

—

Schizophrenia

0.00

0.97

0.0

1.1

—

Voice disturbances

1.80

0.96

1.2

1.0

—

Personality disorders, excluding more controls

1.80

0.96

1.0

1.1

—

Other diseases of upper respiratory tract

141

1.37

0.96

1.2

1.1

—

Lung cancer and mesothelioma

1.93

0.95

1.1

—

Coxarthrosis [arthrosis of hip](FG)

101

0.56

0.95

1.1

—

Somatoform disorder

0.00

0.95

0.0

1.1

—

Concussion

0.50

0.95

1.0

1.2

—

Chronic lower respiratory diseases

163

1.34

0.94

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

142

1.41

0.93

1.0

1.1

—

Diverticular disease of intestine

110

1.45

0.93

1.4

1.1

—

Allergic rhinitis

1.74

0.93

1.0

1.1

—

Personality disorders

1.73

0.92

1.0

1.2

—

Mycoses

1.73

0.92

1.0

1.1

—

Obesity related asthma

1.67

0.91

1.0

1.1

—

Gout

1.70

0.89

1.6

1.1

—

Gout, strict definition

1.91

0.88

1.9

1.1

—

Other/unspecified dorsalgia

1.61

0.88

1.0

1.1

—

Rotator cuff syndrome

108

1.46

0.87

1.3

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

2.00

0.87

1.2

1.1

—

Seborrhoeic keratosis

1.82

0.85

1.3

1.1

—

Inflammatory bowel disease, strict (require KELA)

1.82

0.85

1.3

1.1

—

Other and unspecified disorders of vitreous body

102

1.55

0.85

1.0

1.1

—

Other dorsopathies, not elsewhere classified

127

1.36

0.85

1.1

—

Calculus of kidney and ureter

1.67

0.85

1.0

1.2

—

Adjustment and management of implanted device

1.94

0.84

1.3

1.1

—

Gout, FINNGEN

1.66

0.84

1.6

1.1

—

Dysphagia

1.78

0.84

1.3

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

161

0.69

0.83

1.2

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

1.74

0.82

1.1

—

Use of pramipexole

1.74

0.82

1.0

1.1

—

Polyarthropathies

105

1.43

0.82

1.3

1.1

—

Atopic dermatitis

1.51

0.81

1.2

1.1

—

Acute and subacute iridocyclitis

1.88

0.81

1.3

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

173

0.70

0.81

1.1

—

Complications of surgical and medical care, not elsewhere classified

169

1.34

0.81

1.0

1.1

—

Single spontaneous delivery

0.48

0.81

1.0

1.1

—

Systemic connective tissue disorders

1.64

0.81

1.2

1.1

—

Shoulder lesions

118

1.39

0.81

1.2

1.1

—

Complications of labour and delivery

0.54

0.81

1.0

—

Persons with potential health hazards related to communicable diseases

1.68

0.80

1.1

—

Superficial injury of hip and thigh

0.00

0.79

0.0

1.0

—

Peripheral artery operations in Hilmo

0.00

0.79

0.0

1.0

—

Other systemic involvement of connective tissue

1.67

0.78

1.3

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

0.00

0.78

0.0

1.0

—

Disorders of synovium and tendon

108

0.57

0.78

1.3

1.1

—

Disorders of skin appendages

1.53

0.78

1.0

1.1

—

Other headache syndromes

1.55

0.77

1.1

—

Diseases of inner ear

127

1.45

0.77

1.2

1.1

—

Macular pucker

1.77

0.76

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.77

0.76

1.3

1.1

—

Diabetic maculopathy, excluding more controls

0.00

0.76

0.0

1.1

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.76

0.0

1.0

—

L02BA Anti-estrogens

0.00

0.76

0.0

1.0

—

Symptoms and signs involving the urinary system

145

1.37

0.75

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

131

1.34

0.75

1.1

—

Coxarthrosis

0.58

0.75

1.1

—

Statin medication

112

0.65

0.75

1.1

—

Other disorders of conjunctiva

2.08

0.74

1.2

1.0

—

Spondylopathies (FG)

2.08

0.74

1.4

1.0

—

Reimbursement for rheumatic diseases

132

1.43

0.74

1.2

1.1

—

Endometriosis of ovary

2.03

0.73

1.0

—

Nontoxic goitre/thyroid nodule

1.64

0.73

1.0

—

Endometriosis

1.72

0.73

1.1

—

Disorder of lipoprotein metabolism, unspecified

2.00

0.72

1.4

1.1

—

Other disorders of the musculoskeletal system and connective tissue

2.00

0.72

1.0

1.1

—

Herpesviral [herpes simplex] infections

1.80

0.72

1.0

1.1

—

Periapical abscess

107

0.56

0.72

1.2

1.1

—

Sleep apnoea, including avohilmo

156

1.31

0.72

1.1

—

Metabolic disorders

143

1.32

0.72

1.1

—

Pure hypercholesterolaemia

125

1.36

0.72

1.1

—

Benign neoplasm: Rectum

1.75

0.71

1.1

—

Sleep apnoea

158

1.31

0.71

1.1

—

Noninflammatory disorders of female genital tract

1.63

0.70

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.92

0.70

1.2

1.1

—

Low back pain

126

1.37

0.70

1.2

1.1

—

Genitourinary diseases

1.43

0.70

1.1

1.2

—

Missing teeth due to accident, extraction or parodontitis

149

0.63

0.70

1.0

1.1

—

Intracranial injury

136

0.63

0.69

1.0

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

142

0.63

0.69

1.1

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.68

0.69

1.1

1.0

—

Recurrent or chronic depression

0.53

0.68

1.0

1.2

—

Retinal detachment with retinal break

1.85

0.68

1.0

1.1

—

Chondropathies

1.85

0.68

1.4

1.1

—

Unspecified acute lower respiratory infection

1.85

0.68

1.0

1.1

—

Ectopic pregnancy

1.85

0.68

1.2

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.85

0.68

1.0

1.1

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

1.85

0.68

1.2

1.1

—

Soft tissue disorders related to use, overuse and pressure

1.59

0.68

1.2

1.1

—

Benign lipomatous neoplasm

1.59

0.68

1.0

1.1

—

Pollen allergy

1.83

0.67

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

101

1.45

0.67

1.2

1.1

—

Vasomotor and allergic rhinitis

1.59

0.67

1.0

1.1

—

Fracture of skull and facial bones

1.63

0.66

1.1

1.2

—

Specific personality disorders

1.63

0.66

1.0

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

0.54

0.66

1.2

1.1

—

Dorsalgia

127

1.31

0.66

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

0.53

0.66

1.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.79

0.66

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

141

1.29

0.66

1.2

1.1

—

Obstructed labour due to maternal pelvic abnormality

1.79

0.66

1.2

1.0

—

Cardiodefibrillation

0.52

0.66

1.0

1.1

—

All chronic kidney diseases

104

1.42

0.65

1.2

1.1

—

Delivery

0.57

0.65

1.0

1.1

—

Superficial injury of head

1.59

0.65

1.0

1.1

—

Other specific joint derangements/joint disorders

115

1.35

0.65

1.2

1.1

—

Diseases of the eye and adnexa

1.35

0.64

1.1

—

Seropositive rheumatoid arthritis, strict definition

1.72

0.64

1.0

—

Exclusions for E4_PCOS_BROAD

1.72

0.63

1.0

1.1

—

Non-ischemic cardiomyopathy

1.53

0.63

1.1

—

Glaucoma

132

0.65

0.62

1.2

1.1

—

Injuries to the shoulder and upper arm

180

0.72

0.62

1.0

1.1

—

Intracranial trauma

0.65

0.62

1.0

1.2

—

Acute renal failure

1.63

0.62

1.1

—

Functional dyspepsia

1.63

0.62

1.4

1.1

—

Sulfasalazine

1.63

0.62

1.1

1.0

—

Other (not insulin) diabetes medications

167

0.75

0.61

1.1

—

Diseases of salivary glands

1.59

0.61

1.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1.67

0.61

1.4

1.1

—

Ulcerative colitis (strict definition, require KELA)

1.67

0.61

1.4

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

1.67

0.61

1.2

1.0

—

Diseases of the respiratory system

1.40

0.61

1.1

—

Postpartum care and examination

0.00

0.60

0.0

1.1

—

Mycoses

181

1.30

0.60

1.0

1.1

—

Arthropathic psoriasis

0.00

0.60

0.0

1.2

—

Cervicocranial syndrome

0.00

0.60

0.0

1.1

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.60

0.0

1.1

—

Thyrotoxicosis with diffuse goitre

0.00

0.60

0.0

1.0

—

Complications of procedures, not elsewhere classified

165

1.30

0.60

1.1

—

Superficial injury of shoulder and upper arm

0.00

0.59

0.0

1.1

—

Polymyalgia rheumatica

0.00

0.59

0.0

1.0

—

Tinnitus

1.54

0.59

1.1

1.2

—

Other disorders of eyelid

100

1.43

0.59

1.1

—

Maternal care for known or suspected abnormality of pelvic organs

1.78

0.59

1.0

—

Delivery, wide proxy

0.54

0.58

1.0

1.1

—

Varicose veins

123

0.68

0.58

1.1

—

Retained placenta and membranes, without haemorrhage

0.00

0.58

0.0

1.0

—

Diplopia

0.00

0.58

0.0

1.0

—

Ischaemic heart disease, wide definition

137

0.72

0.58

1.1

—

Retinal breaks without detachment

1.71

0.57

1.2

1.1

—

Special screening examination for infectious and parasitic diseases

1.70

0.57

1.2

—

Other systemic involvement of connective tissue (FG)

1.49

0.57

1.3

1.1

—

Disorders of vitreous body

119

1.38

0.57

1.0

1.1

—

Acute appendicitis, with complications

1.67

0.56

1.2

1.1

—

Covid-19 suspected case

1.67

0.56

1.0

1.1

—

Insomnia

153

1.29

0.56

1.0

1.1

—

Unspecified mental disorder

0.57

0.56

1.0

1.1

—

Irritable bowel syndrome

1.45

0.56

1.0

1.1

—

Accidents

100

1.30

0.55

1.2

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

1.37

0.55

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

138

0.70

0.55

1.3

1.1

—

Disorders of vestibular function (Vertigo)

105

1.41

0.55

1.3

1.1

—

Substance use, excluding alcohol

1.62

0.55

1.0

1.1

—

Endometriosis ASRM stages 3,4

1.62

0.55

1.2

1.0

—

Diseases of pulp and periapical tissues and dental caries

0.70

0.55

1.2

1.1

—

Symptoms and signs involving speech and voice

1.54

0.55

1.3

1.1

—

Exposure to other specified factors

170

1.30

0.55

1.1

—

Anterior Iridocyclitis

1.58

0.54

1.3

1.1

—

Other diseases of the respiratory system

1.58

0.54

1.2

1.1

—

Other respiratory disorders and diseases

1.58

0.54

1.2

1.1

—

Fitting and adjustment of other devices

1.48

0.53

1.1

—

Injuries to the elbow and forearm

160

0.71

0.53

1.1

—

Temporomandibular joint disorders, including avohilmo

1.49

0.53

1.0

1.1

—

Other abnormal uterine and vaginal bleeding

1.53

0.52

1.2

1.1

—

Other joint disorders

116

1.27

0.52

1.1

—

Other hammer toe(s) (acquired)

1.50

0.51

1.0

1.1

—

Nonsuppurative otitis media

1.48

0.51

1.0

1.1

—

Other and unspecified iron deficiency

1.38

0.50

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

140

1.30

0.50

1.2

1.1

—

Focal epilepsy

1.46

0.50

1.0

1.1

—

Carpal tunnel syndrome

148

0.71

0.50

1.0

1.1

—

Complications of medical and surgical care

165

1.28

0.49

1.1

—

Disorders of sclera, cornea, iris and ciliary body

127

1.34

0.49

1.2

1.1

—

Triptan medication for migraine, min. 3 purchases

1.42

0.49

1.0

1.1

—

Disorders of vitreous body and globe

122

1.34

0.49

1.0

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.63

0.49

1.0

1.1

—

Benign neoplasm: Rectum, anus and anal canal

1.56

0.48

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.56

0.48

1.0

1.1

—

Ventral hernia

1.52

0.48

1.0

1.2

—

Erosion of teeth , including avohilmo

1.52

0.48

1.1

—

Fissure and fistula of anal and rectal regions

1.52

0.48

1.0

1.1

—

Insulin medication

140

0.72

0.47

1.2

1.1

—

Fall on same level involving ice and snow

143

0.70

0.47

1.1

—

Other arthrosis

1.33

0.47

1.3

1.1

—

Urticaria and erythema

1.47

0.46

1.0

1.1

—

Transient ischemic attack

125

0.71

0.46

1.0

1.1

—

Gout, unspecified

1.46

0.46

2.0

1.1

—

Other antidepressants

138

1.22

0.46

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

126

1.23

0.46

1.0

1.1

—

Excessive attrition of teeth

120

1.33

0.46

1.0

1.1

—

Subjective visual disturbances

1.43

0.46

1.0

1.1

—

Dorsopathies

128

1.23

0.45

1.1

—

Sleep disorders

157

1.24

0.45

1.0

1.1

—

Meniscus derangement

1.31

0.45

1.3

1.1

—

135

0.72

0.45

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.28

0.44

1.1

—

Chronic diseases of tonsils and adenoids

118

0.75

0.43

1.1

—

Other neurological diseases

155

0.76

0.43

1.0

1.1

—

Polyp of the female genital tract

1.44

0.43

1.0

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

149

0.74

0.43

1.2

1.1

—

COPD (mode)

1.46

0.43

1.5

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1.62

0.43

1.0

1.1

—

Mental and behavioural disorders due to alcohol

126

0.69

0.43

1.0

1.1

—

Other external causes of accidental injury

100

1.25

0.43

1.2

1.1

—

Other arrhythmias

118

1.28

0.43

1.2

1.1

—

Glaucoma suspect

0.65

0.42

1.3

1.1

—

Papulosquamous disorders

0.65

0.42

1.3

1.1

—

Other (seronegative) rheumatoid arthritis, wide

1.56

0.42

1.4

1.0

—

Valvular heart disease excluding rheumatic fever

1.31

0.41

1.1

—

Antihypertensive medication - note that there are other indications

1.29

0.41

1.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.52

0.41

1.0

1.1

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.41

0.0

1.0

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

0.41

0.0

1.0

—

Multiple delivery

0.00

0.41

0.0

1.1

—

Other and unspecified myopathies

0.00

0.41

0.0

1.0

—

Pilonidal cyst

0.00

0.41

0.0

1.1

—

Other diseases of arteries and capillaries

0.00

0.41

0.0

1.0

—

Abscess of anal and rectal regions

0.00

0.41

0.0

1.1

—

Graves disease, strict definition

0.00

0.41

0.0

1.0

—

Procreative management

1.36

0.41

1.1

—

Abdominal aortic aneurysm (AAA)

0.00

0.41

0.0

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.30

0.41

1.1

1.2

—

Diabetic maculopathy

0.00

0.41

0.0

1.1

—

Carcinoma in situ of breast, intraductal

0.00

0.40

0.0

1.0

—

Open wound of ankle and foot

0.00

0.40

0.0

1.1

—

Rosacea

0.00

0.40

0.0

1.1

—

Benign neoplasm of other and ill-defined parts of digestive system

1.47

0.40

1.0

1.1

—

Adverse effects, not elsewhere classified

1.47

0.40

1.8

1.1

—

Valvular operations

1.47

0.40

1.0

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

1.47

0.40

1.0

1.1

—

Angina pectoris

115

0.75

0.40

1.1

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.40

0.0

1.2

—

Vitreous haemorrhage

0.00

0.40

0.0

1.0

—

Other psoriatic arthropathies

0.00

0.40

0.0

1.1

—

Superficial injury of forearm

0.00

0.40

0.0

1.1

—

Psoriatic arthropathies

0.00

0.40

0.0

1.1

—

Otitis externa, unspecified

0.00

0.40

0.0

1.1

—

Disorders of parathyroid gland

1.45

0.40

1.2

1.0

—

Leiomyoma of uterus

1.33

0.39

1.0

1.1

—

Maternal care for other known or suspected fetal problems

1.44

0.39

1.0

1.1

—

Gout, idiopatic and unspecified

1.31

0.39

1.9

1.1

—

Familial hypercholesterolemia

1.43

0.39

1.4

1.1

—

Psoriatic arthropathies, ICD10

0.00

0.39

0.0

1.2

—

Burns and corrosions of external body surface, specified by site

0.00

0.39

0.0

1.1

—

All dysplastic lesions of the cervix uteri

1.42

0.39

1.2

1.0

—

Fenamates

1.41

0.39

1.0

1.2

—

Persons encountering health services for examination and investigation

1.29

0.39

1.1

1.2

—

Acetic acid derivatives and related substances

1.33

0.38

1.2

—

Diseases of middle ear and mastoid

101

1.30

0.38

1.0

1.1

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.39

0.38

1.1

1.0

—

Lichen planus, including avohilmo

1.39

0.38

1.0

1.1

—

Focal epilepsy, strict definition

1.39

0.38

1.0

1.1

—

Peripheral artery disease

0.70

0.37

1.0

1.2

—

Behavioural syndromes associated with physiological disturbances and physical factors

165

1.20

0.37

1.0

1.1

—

133

0.75

0.37

1.0

1.1

—

Other functional intestinal disorders

1.33

0.37

1.2

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.45

0.35

1.2

1.1

—

Abnormal serum enzyme levels

0.62

0.35

1.0

1.2

—

All anxiety disorders

1.28

0.35

1.0

1.1

—

Primary open-angle glaucoma

0.62

0.35

1.2

1.1

—

Gestational diabetes (for exclusion)

1.39

0.35

1.0

1.1

—

Caries of enamel

156

1.20

0.35

1.1

—

Insulin, intermediate and long-acting

141

0.76

0.34

1.2

1.1

—

Disturbances of skin sensation

1.36

0.34

1.0

1.1

—

Contact with and exposure to communicable diseases

1.36

0.34

1.0

1.1

—

Injuries to the neck

1.33

0.33

1.2

1.1

—

Cervicobrachial syndrome

1.33

0.33

1.0

1.1

—

Contraceptive management

0.67

0.33

1.2

1.1

—

COPD, hospital admissions 1, only main diagnosis

0.68

0.33

1.0

1.1

—

Dental pulpitis, including avohilmo

151

0.82

0.33

1.2

1.1

—

Dizziness and giddiness

151

1.21

0.33

1.1

—

Other cataract

1.28

0.33

1.1

1.2

—

Sensorineural hearing loss

143

0.81

0.33

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

0.68

0.33

1.0

1.1

—

Insulin, fast-acting or short human

0.68

0.33

1.0

1.1

—

Insulin, fast-acting

0.67

0.32

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

177

1.20

0.32

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.27

0.32

1.0

1.1

—

Neurological diseases, wide definition

1.35

0.32

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.30

0.32

1.1

1.2

—

Cholelithiasis

151

1.19

0.31

1.0

1.1

—

Diseases of the musculoskeletal system and connective tissue

1.27

0.31

1.1

—

Postmenopausal atrophic vaginitis

1.29

0.30

1.0

1.1

—

Benzodiazepine use

177

1.17

0.30

1.0

1.1

—

Continuous positive airway pressure

1.28

0.30

1.3

1.2

—

Allergic conjunctivitis

108

1.26

0.30

1.0

1.1

—

Early onset COPD

1.25

0.29

1.6

1.1

—

Non-rheumatic valve diseases

1.24

0.29

1.1

—

Ovarian cyst

1.32

0.29

1.1

—

Alcohol use disorder, ICD-based

108

0.74

0.29

1.0

1.1

—

Alcohol use disorder, Swedish definition

129

0.78

0.28

1.0

1.1

—

Hallux valgus (acquired)

1.33

0.28

1.0

1.1

—

Gonarthrosis,primary

154

0.84

0.28

1.2

1.1

—

Bleeding

162

0.83

0.28

1.1

—

Dyspnoea

164

1.17

0.28

1.1

—

Disorders of breast

1.28

0.28

1.0

—

Ischemic heart diseases

137

0.83

0.28

1.1

—

Suppurative and unspecified otitis media

1.29

0.28

1.0

1.1

—

Diseases of external ear

1.32

0.28

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.29

0.28

1.1

1.0

—

Presence of cardiac and vascular implants and grafts

0.77

0.28

1.2

1.1

—

Fall on same level

162

1.15

0.27

1.1

—

Benign paroxysmal vertigo

1.25

0.27

1.4

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

116

0.77

0.27

1.0

1.1

—

Propionic acid derivatives

0.66

0.27

1.0

1.2

—

Anti-inflammatory and antirheumatic products, non-steroids

0.66

0.27

1.0

1.2

—

Blepharochalasis

1.23

0.27

1.0

—

Hypothyroidism, other/unspecified

149

0.84

0.27

1.1

—

Artrosis, including avohilmo

130

0.84

0.26

1.3

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

101

1.25

0.26

1.0

1.1

—

Episodal and paroxysmal disorders

142

1.15

0.26

1.0

1.1

—

Other diseases of anus and rectum

1.19

0.26

1.3

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.70

0.26

1.0

1.2

—

Other disorders of fluid, electrolyte and acid-base balance

0.68

0.26

1.4

1.1

—

Infections of the skin and subcutaneous tissue

137

0.79

0.26

1.0

1.1

—

Kela-code for severe mental illness

0.68

0.26

1.0

1.1

—

Cerebrovascular diseases (FINNGEN)

1.20

0.25

1.1

1.2

—

Other diseases of the digestive system

1.22

0.25

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

166

1.15

0.25

1.0

1.1

—

Rheumatoid arthritis

1.20

0.25

1.2

1.1

—

Emergency coronary revascularization (for ACS)

143

0.85

0.24

1.1

—

Atrial fibrillation and flutter

0.71

0.24

1.2

—

Keratitis

1.18

0.24

1.0

1.1

—

Diabetic retinopathy, excluding more controls

1.40

0.24

1.2

—

Renal failure

101

1.23

0.24

1.1

—

Myocardial infarction, strict

0.79

0.24

1.1

1.2

—

Type 2 diabetes, wide definition

143

0.85

0.24

1.1

—

Other diseases of hard tissues of teeth

1.20

0.23

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

122

0.81

0.23

1.3

1.1

—

Persons encountering health services in other circumstances

1.28

0.23

1.2

1.1

—

Major coronary heart disease event

141

0.86

0.23

1.1

—

Persistent mood disorders

1.32

0.23

1.2

1.1

—

Acute pancreatitis (for exclusion)

1.32

0.23

1.2

1.1

—

Complications predominantly related to the puerperium

1.32

0.23

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

143

0.85

0.23

1.1

—

Visual disturbances and blindness

125

0.80

0.23

1.2

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.22

0.23

1.2

1.0

—

Diseases of oral cavity, salivary glands and jaws

1.20

0.22

1.2

1.1

—

Disorders of gallbladder, biliary tract and pancreas

161

1.14

0.22

1.0

1.1

—

Non-selective monoamine reuptake inhibitors

0.75

0.22

1.0

1.2

—

Acute pancreatitis

1.25

0.22

1.2

1.1

—

Peritonsillar abscess

1.25

0.22

1.2

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

0.74

0.22

1.3

1.1

—

Diseases of the digestive system

106

1.22

0.22

1.1

—

Cardiomyopathy

1.22

0.22

1.0

1.1

—

Sequelae of cerebrovascular disease

1.25

0.22

1.2

1.1

—

Dental caries, including avohilmo

108

0.85

0.21

1.1

—

Disorders of psychological development

0.00

0.21

0.0

1.0

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

0.21

0.0

1.0

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.21

0.0

1.1

—

Astigmatism

0.00

0.21

0.0

1.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

0.21

0.0

1.0

—

Other secondary gonarthrosis

0.00

0.21

0.0

1.0

—

Dystonia

0.00

0.21

0.0

1.0

—

Convalescence

0.00

0.21

0.0

1.0

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.21

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

0.21

0.0

1.0

—

Osteomyelitis

0.00

0.21

0.0

1.0

—

Psychotic depression

0.00

0.21

0.0

1.1

—

Cyst of kidney

0.00

0.21

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.21

0.0

1.1

—

Dermatographic urticaria

0.00

0.21

0.0

1.0

—

Other and unspecified glaucoma

0.00

0.21

0.0

1.0

—

Visual impairment including blindness (binocular or monocular)

0.00

0.21

0.0

1.0

—

Invasive ventilation

0.00

0.21

0.0

1.0

—

Hydrocephalus

0.00

0.21

0.0

1.0

—

MS-disease / Multiple Sclerosis

0.00

0.21

0.0

1.1

—

Use of galantamine

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

1.2

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

1.1

—

Other and unspecified mood [affective] disorders

0.00

0.21

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

0.21

0.0

1.2

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

1.1

—

Asthma/COPD (KELA code 203)

163

1.14

0.21

1.0

1.1

—

Undefined dementia

0.00

0.21

0.0

1.0

—

Unstable angina pectoris

0.77

0.21

1.1

1.2

—

Medial epicondylitis

0.00

0.21

0.0

1.0

—

Other specified/unspecified soft tissue disorders

0.00

0.21

0.0

1.0

—

Neuralgia and neuritis, unspecified

0.00

0.21

0.0

1.0

—

Tongue abnormality

0.00

0.21

0.0

1.0

—

Presbyopia

0.00

0.21

0.0

1.1

—

Alcohol withdrawal state with delirium

0.00

0.21

0.0

1.3

—

Amputation of toe

0.00

0.21

0.0

1.0

—

Thyroiditis

0.00

0.21

0.0

1.0

—

Mental disorders, not otherwise specified

0.00

0.21

0.0

1.0

—

Disease of hard tissues of teeth, NOS

1.20

0.21

1.3

1.1

—

Congenital malformations of genital organs

0.00

0.21

0.0

1.0

—

Vascular dementia

0.00

0.21

0.0

1.0

—

Caries of dentine, including avohilmo

113

0.86

0.21

1.1

—

Cervicalgia

1.16

0.21

1.0

1.1

—

Artificial joint re-operation

0.00

0.21

0.0

1.0

—

Other and unspecified psoriasis

0.00

0.21

0.0

1.0

—

Corns and callosities

0.00

0.21

0.0

1.0

—

Other and unspecified rosacea

0.00

0.21

0.0

1.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.21

0.0

1.0

—

Amputation

0.00

0.21

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.20

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

0.20

0.0

1.0

—

Acute laryngitis and tracheitis

0.00

0.20

0.0

1.0

—

Divergent concomitant strabismus

0.00

0.20

0.0

1.1

—

Normotensive glaucoma

0.00

0.20

0.0

1.0

—

Persistent delusional disorders

0.00

0.20

0.0

1.1

—

Nasal polyp

1.25

0.20

1.3

1.1

—

Unspecified dementia

0.00

0.20

0.0

1.0

—

Degeneration of macula and posterior pole

1.20

0.20

1.1

—

Atopic dermatitis, strict definition with reimbursement

1.23

0.20

1.0

1.1

—

Injuries to the hip and thigh

102

0.80

0.20

1.0

1.1

—

Other and unspecified effects of external causes

1.22

0.20

1.7

1.1

—

Hernia of abdominal wall

111

0.81

0.20

1.0

1.1

—

Inflammatory diseases of female pelvic organs

1.20

0.19

1.1

1.0

—

Effects of foreign body entering through natural orifice

1.20

0.19

1.2

—

Obesity due to excess calories

1.21

0.19

1.1

—

Mouth breathing

1.21

0.19

1.0

1.1

—

Retinal detachments and breaks

1.22

0.19

1.1

—

Postmenopausal bleeding

1.24

0.19

1.0

1.1

—

Obesity

141

1.16

0.19

1.1

—

Paroxysmal tachycardia

1.14

0.19

1.0

1.2

—

Menorrhagia

1.21

0.18

1.0

1.1

—

Injuries to the wrist and hand

180

0.88

0.18

1.0

1.1

—

Obesity and other hyperalimentation

141

1.16

0.18

1.1

—

Spondylosis

108

0.83

0.18

1.0

1.1

—

Colonic or urogenital fistula

1.21

0.18

1.0

1.1

—

Coronary revascularization (ANGIO or CABG)

133

0.87

0.18

1.1

—

Other specified/unspecified arthritis

1.17

0.17

1.3

1.1

—

Percutaneous Coronary Intervention

133

0.88

0.17

1.1

—

Persons encountering health services in circumstances related to reproduction

0.83

0.17

1.2

1.1

—

Artificial joint operation, meniscal resection

161

0.89

0.17

1.3

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.72

0.17

1.0

—

Conductive and sensorineural hearing loss

146

0.88

0.17

1.1

—

L02BG Aromatase inhibitors

1.13

0.17

1.1

1.0

—

Calcific aortic valvular stenosis, operated

1.11

0.17

1.0

1.1

—

Calcific aortic valvular stenosis

1.11

0.17

1.0

1.1

—

Operations 2 for CAVS

1.11

0.17

1.0

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

1.11

0.17

1.0

1.1

—

Calcific aortic valvular stenosis, including rheumatic fever

1.11

0.17

1.0

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

0.75

0.17

1.2

1.1

—

Other retinal disorders

135

0.87

0.16

1.1

—

Other enthesopathies

1.18

0.16

1.4

1.1

—

Striking against or struck by other objects

1.18

0.16

1.0

1.1

—

Epilepsy

1.17

0.16

1.0

1.2

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

155

0.89

0.16

1.1

—

Hyperplasia of prostate

1.19

0.16

1.1

1.2

—

Heart failure and coronary heart disease

0.83

0.16

1.1

1.2

—

Cholelithiasis, broad definition with cholecystitis

151

1.11

0.16

1.0

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.75

0.15

1.0

—

Diseases of arteries, arterioles and capillaries

135

0.88

0.15

1.1

—

Cholecystectomy

153

1.13

0.15

1.0

1.1

—

Cervical disc disorders

1.20

0.15

1.2

1.1

—

Abnormalities of heart beat

1.15

0.15

1.1

—

Dental operations

1.14

0.15

1.2

1.1

—

Neurological diseases

108

1.12

0.15

1.0

1.2

—

Spontaneous abortion

1.10

0.15

1.0

1.1

—

Retention of urine

1.09

0.14

1.1

1.2

—

Heart failure, strict

112

1.13

0.14

1.1

—

Major coronary heart disease event excluding revascularizations

121

0.88

0.14

1.1

—

Nerve, nerve root and plexus disorders

175

0.91

0.14

1.1

—

STROKE

109

0.87

0.14

1.1

—

Visual disturbances

117

0.85

0.13

1.2

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.17

0.12

1.1

1.2

—

Mental and behavioural disorders due to psychoactive substance use

137

0.88

0.12

1.0

1.1

—

Open wound of wrist and hand

111

1.14

0.12

1.0

1.1

—

Other nutritional deficiencies

143

1.12

0.12

1.1

—

Excessive earwax

139

1.12

0.12

1.0

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

116

1.11

0.11

1.1

—

Triptan medication for migraine, single purchase ok

116

1.11

0.11

1.1

—

Nutritional anaemias

111

1.13

0.10

1.1

—

Injuries to the ankle and foot

148

0.90

0.10

1.1

—

Female infertility, cervical, vaginal, other or unspecified origin

1.12

0.10

1.0

1.1

—

Arthrosis

103

0.91

0.10

1.4

1.1

—

Diabetic retinopathy

1.07

0.09

1.2

1.1

—

Arthropathies

117

1.08

0.09

1.1

—

Otitis externa

1.09

0.09

1.0

1.1

—

Injuries to the thorax

114

0.88

0.09

1.1

—

Cardiac arrhythmias

100

1.10

0.09

1.1

—

Atopic dermatitis, strict definition

1.06

0.09

1.0

1.1

—

Myocardial infarction

0.89

0.09

1.1

1.2

—

Other gastritis (incl. Duodenitis)

1.04

0.09

1.0

1.1

—

Other menopausal disorders

1.13

0.09

1.0

1.1

—

Dermatophytosis

145

1.10

0.09

1.1

—

Injuries to the knee and lower leg

172

1.06

0.09

1.1

—

Medical abortion

1.12

0.08

1.0

1.1

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.07

0.08

1.0

1.1

—

Constipation

157

0.93

0.08

1.0

1.1

—

COPD

101

0.89

0.08

1.4

1.1

—

Type 1 diabetes

0.83

0.08

1.0

1.1

—

Senile cataract

107

1.09

0.08

1.2

1.1

—

Other and unspecified tonsillitis

1.09

0.08

1.9

1.1

—

Disorders of choroid and retina

152

1.08

0.08

1.1

—

Infections with a predominantly sexual mode of transmission

0.83

0.07

1.0

1.1

—

GI-bleeding

0.82

0.07

1.2

1.1

—

Fracture of rib(s), sternum and thoracic spine

0.81

0.07

1.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

0.80

0.07

1.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.80

0.07

1.0

1.1

—

Heart failure and antihypertensive medication

0.83

0.07

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

118

1.09

0.07

1.0

1.1

—

Internal derangement of knee

1.05

0.07

1.1

—

Substance abuse

134

0.91

0.07

1.0

1.1

—

Rheumatoid arthritis, including avohilmo

1.05

0.07

1.2

1.1

—

Fracture of shoulder and upper arm

1.03

0.07

1.0

1.1

—

Other disorders of veins

0.86

0.06

1.1

—

Depression

166

1.06

0.06

1.1

—

Selective serotonin reuptake inhibitors

138

1.06

0.06

1.0

1.1

—

Heart failure,strict

104

1.09

0.06

1.1

—

Transport accidents

0.87

0.06

1.1

—

Other disorders of ear

160

0.94

0.06

1.0

1.1

—

Fracture of lower leg, including ankle

137

1.08

0.06

1.1

—

Diseases of the ear and mastoid process

153

0.95

0.05

1.0

1.1

—

Other disorders of urethra and urinary system

107

1.08

0.05

1.1

—

Psychiatric diseases

138

1.05

0.05

1.0

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

141

0.92

0.05

1.2

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

130

0.92

0.05

1.0

1.1

—

External causes of morbidity and mortality

1.07

0.05

1.1

—

Injury, poisoning and certain other consequences of external causes

0.92

0.05

1.1

—

Other anxiety disorders

1.11

0.05

1.0

1.1

—

All-cause Heart Failure

112

1.07

0.05

1.1

—

Unspecified fall

118

1.09

0.05

1.1

—

Gonarthrosis

1.07

0.05

1.2

1.1

—

Fracture of forearm

119

0.92

0.04

1.1

—

Other diseases of lip and oral mucosa

1.10

0.04

1.0

1.1

—

Disorders of lens

112

1.06

0.04

1.2

1.1

—

Substance abuse, excluding more controls

119

0.93

0.04

1.0

1.2

—

Other chronic obstructive pulmonary disease

0.92

0.03

1.4

1.1

—

Disorders of the thyroid gland

156

1.04

0.03

1.1

—

Diseases of male genital organs

1.07

0.03

1.2

—

Injuries to the head

178

1.04

0.03

1.1

—

Any mental disorder

150

1.03

0.03

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

116

1.07

0.03

1.0

1.1

—

Open wound of head

133

0.94

0.02

1.0

1.1

—

Pain in limb

128

1.04

0.02

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

150

1.05

0.02

1.1

—

Anxiety (asthma-related co-morbidities)

110

1.05

0.02

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

126

0.95

0.01

1.1

—

Endocrine, nutritional and metabolic diseases

100

0.96

0.01

1.1

—

Spinal stenosis

0.95

0.01

1.0

1.1

—

COPD, early/later onset

0.95

0.01

1.4

1.1

—

Hard cardiovascular diseases

139

1.03

0.01

1.1

—

Cerebrovascular diseases

143

1.03

0.01

1.1

—

Soft tissue disorders

132

0.97

0.00

1.1

—

Gonarthrosis [arthrosis of knee](FG)

114

0.97

0.00

1.2

1.1

—

Exposure to unspecified factor

184

1.02

0.00

1.2

1.1

—

Anxiety disorders

159

1.01

0.00

1.0

1.1

—

Myocardial infarction, without ST-elevation

0.95

0.00

1.1

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

163

0.98

0.00

1.1

—

Inguinal hernia

1.01

0.00

1.1

1.2

—

Iron deficiency anaemia

1.05

0.00

1.1

—

COPD, hospital admissions

0.97

0.00

1.4

1.1

—

Pregnancy with abortive outcome

1.00

0.00

1.0

1.1

—

Hypothyroidism, strict autoimmune

110

1.02

0.00

1.1

—

Benign neoplasm: Colon

139

1.03

0.00

1.3

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

1.04

0.00

1.0

1.2

—

Spondylopathies

116

1.03

0.00

1.1

—

Anxiety disorders, excluding more controls

138

0.99

0.00

1.0

1.1

—

Unspecified haematuria

1.04

0.00

1.1

1.2

—

Hyperlipidaemia, other/unspecified

0.97

0.00

1.1

—

Mood disorders

175

1.00

0.00

1.1

—

Depression or dysthymia

0.97

0.00

1.1

—

Neurotic, stress-related and somatoform disorders

157

1.02

0.00

1.0

1.1

—

Necrosis of pulp, including avohilmo

129

1.00

0.00

1.3

1.1

—

Mood [affective] disorders

175

1.00

0.00

1.1

—

Falls/tendency to fall

146

0.99

0.00

1.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

113

0.97

0.00

1.1

—

Mood disorders, excluding more controls

149

1.00

0.00

1.1

—

Extracorporeal dialysis

0.00

0.0

1.0

—

Moderate visual impairment, binocular

0.00

0.0

1.0

—

L02BX Other hormone antagonists and related agents

0.00

0.0

1.0

—

Herpesviral keratitis and keratoconjunctivitis

0.00

0.0

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

0.99

0.00

1.0

1.2

—

Convergent concomitant strabismus

0.00

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.0

—

Other arthritis (FG)

0.96

0.00

1.3

1.0

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

0.0

1.0

—

Acute posthaemorrhagic anaemia

0.00

0.0

1.0

—

Injury of nerves at wrist and hand level

0.00

0.0

1.0

—

Laparoscopic right hemicolectomy

0.00

0.0

1.0

—

Fracture of femur

0.84

0.00

1.0

1.1

—

Fracture of neck

0.00

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

0.0

1.0

—

Other diseases of peritoneum

0.00

0.0

1.0

—

Tobacco use

0.00

0.0

1.0

—

Follow-up care involving plastic surgery

0.00

0.0

1.0

—

Oesophagitis

0.00

0.0

1.0

—

Female infertility, associated with anovulation

0.00

0.0

1.2

—

Systemic atrophies primarily affecting the central nervous system

0.00

0.0

1.0

—

Sub-endpoint used in defining T1D endpoints

0.83

0.00

1.0

1.1

—

Colorectal adenocarcinoma

0.00

0.0

1.0

—

Speech and linguistic disorders, excluding more controls

0.00

0.0

1.0

—

Use of selegiline

0.00

0.0

1.0

—

Cirrhosis of liver, NAS

0.00

0.0

1.0

—

Primary angle-closure glaucoma

0.00

0.0

1.0

—

Muscle strain

0.00

0.0

1.0

—

Other and unspecified disease of Bartholin gland

0.00

0.0

1.0

—

Monoarthritis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Prolapse and hernia of ovary and fallopian tube

0.00

-0.00

0.0

1.0

—

Intestinal malabsorption

0.00

-0.00

0.0

1.0

—

Normal-pressure hydrocephalus

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

1.0

—

Chronic tubulo-interstitial nephritis

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Colon, unspecified

1.02

-0.00

1.2

1.1

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

1.0

—

Other specified disorders of muscle

0.00

-0.00

0.0

1.0

—

Gluteal tendinitis

0.00

-0.00

0.0

1.0

—

Desensitization to allergens

0.00

-0.00

0.0

1.0

—

Fall involving bed

0.00

-0.00

0.0

1.0

—

Extreme obesity with alveolar hypoventilation

0.00

-0.00

0.0

1.0

—

Unspecified abortion

0.00

-0.00

0.0

1.1

—

Other surgical follow-up care

0.00

-0.00

0.0

1.0

—

Arthropathies in other diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.0

—

Oral lichen planus

0.00

-0.00

0.0

1.0

—

Other acquired deformities of musculoskeletal system and connective tissue

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of cervix uteri

0.00

-0.00

0.0

1.0

—

Other disorders of pigmentation

0.00

-0.00

0.0

1.0

—

Abnormal blood-pressure reading, without diagnosis

0.00

-0.00

0.0

1.0

—

Paralytic ileus

0.00

-0.00

0.0

1.0

—

Acute generalized exanthematous pustulosis

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

-0.00

0.0

1.0

—

Hypertensive heart and/or renal disease

0.95

-0.00

1.6

1.2

—

Pericarditis

0.00

-0.00

0.0

1.0

—

Diseases of tongue

0.00

-0.00

0.0

1.0

—

Scar conditions and fibrosis of skin

0.00

-0.00

0.0

1.0

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

1.0

—

Injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Placenta praevia

0.00

-0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.0

—

Female infertility

0.98

-0.00

1.0

1.1

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

-0.00

0.0

1.0

—

Lesion of lateral popliteal nerve

0.00

-0.00

0.0

1.0

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.0

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Secondary right heart disease

0.00

-0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.0

—

Sequelae of external causes of morbidity and mortality

0.91

-0.00

1.0

1.1

—

Unspecified chronic bronchitis

0.00

-0.00

0.0

1.0

—

Other or ill-defined heart diseases

0.00

-0.00

0.0

1.0

—

Chronic kidney disease

0.99

-0.00

1.3

1.1

—

Heart failure and bmi 25plus

0.96

-0.00

1.1

—

Other pulmonary heart/vessel disease

0.00

-0.00

0.0

1.0

—

Deforming dorsopathies

0.95

-0.00

1.0

1.1

—

Fibroblastic disorders

0.89

-0.00

1.0

1.1

—

Event of undetermined intent

0.00

-0.00

0.0

1.1

—

Conduction disorders

0.98

-0.00

1.1

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

-0.00

0.0

1.0

—

Speech and linguistic disorders

0.00

-0.00

0.0

1.0

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

-0.00

0.0

1.0

—

Urticaria

0.89

-0.00

1.0

1.1

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

1.0

—

Arterial embolism and thrombosis of lower extremity artery

0.00

-0.00

0.0

1.0

—

Seropositive rheumatoid arthritis, wide

0.96

-0.00

1.0

1.1

—

Optic neuritis

0.00

-0.00

0.0

1.0

—

Sequelae of other and unspecified infectious and parasitic diseases

0.00

-0.00

0.0

1.1

—

Lesion of plantar nerve

0.00

-0.00

0.0

1.0

—

Excessive, frequent and irregular menstruation

0.89

-0.00

1.0

1.1

—

Type1 diabetes, definitions combined, early onset

0.00

-0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.2

—

Separation of retinal layers (serosa)

0.00

-0.00

0.0

1.2

—

Hypertrophic scar

0.00

-0.00

0.0

1.0

—

Adrenocortical insufficiency

0.00

-0.00

0.0

1.0

—

Other hearing loss

0.93

-0.00

1.2

1.1

—

Gonococcal infection

0.00

-0.00

0.0

1.0

—

Autoimmune hyperthyroidism

0.00

-0.00

0.0

1.0

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.1

—

Other neurotic disorders

0.00

-0.00

0.0

1.0

—

Decubitus ulcer and pressure area

0.00

-0.00

0.0

1.0

—

Impingement syndrome of shoulder

0.94

-0.00

1.2

1.1

—

Female genital prolapse

0.91

-0.00

1.0

1.1

—

Other disorders of adrenal gland

0.00

-0.00

0.0

1.0

—

Maternal care for cervical incompetence

0.00

-0.00

0.0

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

1.01

-0.00

1.6

1.1

—

COPD, hospital admission 2, with asthma infections

0.99

-0.00

1.5

1.1

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

1.0

—

Congenital ovarian cysts

0.00

-0.00

0.0

1.0

—

Other benign neoplasm of uterus: Other parts/unspecified

0.00

-0.00

0.0

1.0

—

Other obstetric trauma

0.00

-0.00

0.0

1.0

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.00

-0.00

0.0

1.1

—

COPD related to multimorbidity

0.92

-0.00

1.0

1.1

—

Generalized skin eruption due to drugs and medicaments

0.00

-0.00

0.0

1.0

—

Infections with a predominantly sexual mode of transmission

0.96

-0.00

1.0

1.1

—

Alzheimer’s disease (Early onset)

0.00

-0.00

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.0

—

Abnormal findings on examination of urine, without diagnosis

0.00

-0.00

0.0

1.0

—

Bursitis of shoulder

0.00

-0.00

0.0

1.0

—

Gonococcal infection

0.00

-0.00

0.0

1.0

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

Other salmonella infections

0.00

-0.00

0.0

1.0

—

Rubella [German measles]

0.00

-0.00

0.0

2.0

—

Open bite

0.00

-0.00

0.0

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.89

-0.00

1.0

1.2

—

0.00

-0.00

0.0

1.0

—

Haemorrhoids and perianal venous thrombosis

0.96

-0.00

1.4

1.1

—

Other diseases of gallbladder

0.00

-0.00

0.0

1.0

—

Coxibs

0.90

-0.00

1.2

—

Use of rasagiline

0.00

-0.00

0.0

1.0

—

Use of ropinirole

0.00

-0.00

0.0

1.0

—

Pyothorax

0.00

-0.00

0.0

1.0

—

Use of biperiden

0.00

-0.00

0.0

1.0

—

L01XE Protein kinase inhibitors

0.00

-0.00

0.0

1.0

—

Pacemaker

0.89

-0.00

1.3

1.1

—

Other and unspecified abdominal hernia

0.00

-0.00

0.0

1.0

—

Total colectomy

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.0

—

Pregnancy hypertension

1.00

-0.00

1.0

—

Medicines for HER+ breast cancer

0.98

-0.00

1.1

1.0

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.0

—

Other symptoms and signs involving general sensations and perceptions

0.00

-0.00

0.0

1.0

—

Postpartum haemorrhage due to anatomy

0.00

-0.00

0.0

1.0

—

Total colectomy operation

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

1.0

—

Other/unspecified seropositive rheumatoid arthritis

0.96

-0.00

1.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.00

-0.00

1.0

1.1

—

Superficial injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Seropositive rheumatoid arthritis

0.87

-0.00

1.0

1.1

—

Other secondary coxarthrosis

0.00

-0.00

0.0

1.0

—

Other epidermal thickening

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.98

-0.00

1.3

1.1

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

-0.00

0.0

1.0

—

Erosion and ectropion of cervix uteri

0.00

-0.00

0.0

1.0

—

Other and unspecified intracranial injuries

0.00

-0.00

0.0

1.0

—

Lesion of sciatic nerve

0.00

-0.00

0.0

1.0

—

Subacute thyroiditis

0.00

-0.00

0.0

1.0

—

Failed induction of labour

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS